| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 16.468 | 63.441 | 62.559 | 77.491 | 77.675 | 72.683 | 84.744 |
| Total Income - EUR | - | - | - | 16.469 | 63.442 | 66.131 | 77.493 | 77.678 | 72.685 | 84.745 |
| Total Expenses - EUR | - | - | - | 12.136 | 35.091 | 33.726 | 35.674 | 41.494 | 41.034 | 43.207 |
| Gross Profit/Loss - EUR | - | - | - | 4.333 | 28.351 | 32.406 | 41.819 | 36.184 | 31.650 | 41.538 |
| Net Profit/Loss - EUR | - | - | - | 4.168 | 27.717 | 31.993 | 41.093 | 35.422 | 30.938 | 39.046 |
| Employees | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Cardiolidmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 12.446 | 7.682 | 6.373 | 5.155 | 5.186 | 3.945 | 6.339 |
| Current Assets | - | - | - | 10.473 | 23.034 | 50.653 | 38.780 | 34.611 | 42.565 | 59.575 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 579 | 3.012 | 27.334 | 35.743 | 32.625 | 29.510 | 31.351 |
| Cash | - | - | - | 9.894 | 20.022 | 23.319 | 3.037 | 1.986 | 13.056 | 28.224 |
| Shareholders Funds | - | - | - | 4.211 | 27.767 | 32.043 | 41.142 | 35.471 | 30.987 | 39.094 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 18.707 | 2.949 | 24.984 | 2.794 | 4.326 | 15.523 | 26.820 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cardiolidmed S.r.l.